BioMarin

YTD

ALL

Trade BioMarin 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BMRN

BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307.

CEO

Alexander Hardy

CEOAlexander Hardy

Employees

3,040

Employees3,040

Headquarters

San Rafael, California

HeadquartersSan Rafael, California

Founded

1997

Founded1997

Employees

3,040

Employees3,040

BMRN Key Statistics

Market cap

11.52B

Market cap11.52B

Price-Earnings ratio

22.46

Price-Earnings ratio22.46

Dividend yield

—

Dividend yield—

Average volume

2.23M

Average volume2.23M

High today

$60.20

High today$60.20

Low today

$60.20

Low today$60.20

Open price

$58.39

Open price$58.39

Volume

320.00

Volume320.00

52 Week high

$73.51

52 Week high$73.51

52 Week low

$50.76

52 Week low$50.76

Stock Snapshot

The current BioMarin(BMRN) stock price is $60.20, with a market capitalization of 11.52B. The stock trades at a price-to-earnings (P/E) ratio of 22.46.

As of 2026-02-13, BioMarin(BMRN) stock has fluctuated between $60.20 and $60.20. The current price stands at $60.20, placing the stock 0.0% above today's low and 0.0% off the high.

The BioMarin(BMRN)'s current trading volume is 320, compared to an average daily volume of 2.23M.

In the last year, BioMarin(BMRN) shares hit a 52-week high of $73.51 and a 52-week low of $50.76.

BMRN News

Simply Wall St 5h

BioMarin Balances VOXZOGO Canada Win With Debt Funded Amicus Expansion

BioMarin Pharmaceutical (NasdaqGS:BMRN) received a Notice of Compliance with Conditions from Health Canada for VOXZOGO, expanding access to its achondroplasia t...

TipRanks 17h

BioMarin Raises $850 Million Notes for Amicus Acquisition

The latest update is out from BioMarin Pharmaceutical ( (BMRN) ). On February 12, 2026, BioMarin Pharmaceutical Inc. closed a private offering of $850 million...

Simply Wall St 2d

Is BioMarin Pharmaceutical Now Trading Below Its Long Term Prospects

If you are wondering whether BioMarin Pharmaceutical's current share price lines up with its underlying worth, this article will walk you through what the numbe...

Analyst ratings

78%

of 27 ratings

Buy

77.8%

Hold

22.2%

Sell

More BMRN News

Simply Wall St 6d

A Look At BioMarin Pharmaceutical Valuation After Recent Share Price Momentum

Advertisement Setting the scene for BioMarin Pharmaceutical BioMarin Pharmaceutical (BMRN) has been drawing attention after recent share price swings, with a...

People also own

Based on the portfolios of people who own BMRN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.